epipen jr 0.15mg/0.3ml injection syringe
alphapharm pty ltd - adrenaline (epinephrine), quantity: 0.5 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; sodium chloride; hydrochloric acid - for the emergency treatment of anaphylactic reactions to insect stings through immediate self administration by individuals with a history of hypersensitivity to insect stings. epipen and epipen jr. are designated as emergency supportive therapy only and are not a replacement or substitute for subsequent medical or hospital care, nor are they intended to supplant insect venom hyposensitization. indications as at 17 june 2003: for the emergency treatment of anaphylaxis (acute severe allergic reactions) due to insect stings, drugs or other allergens.
epipen 0.3mg/0.3ml injection syringe auto-injector
alphapharm pty ltd - adrenaline (epinephrine), quantity: 1 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; water for injections; hydrochloric acid - for the emergency treatment of anaphylactic reactions to insect stings through immediate self administration by individuals with a history of hypersensitivity to insect stings. epipen and epipen jr. are designated as emergency supportive therapy only and are not a replacement or substitute for subsequent medical or hospital care, nor are they intended to supplant insect venom hyposensitization. indications as at 17 june 2003: for the emergency treatment of anaphylaxis (acute severe allergic reactions) due to insect stings, drugs or other allergens for the emergency treatment of anaphylactic reactions to insect stings through immediate self administration by individuals with a history of hypersensitivity to insect stings. epipen and epipen jr. are designated as emergency supportive therapy only and are not a replacement or substitute for subsequent medical or hospital care, nor are they intended to supplant insect venom hyposensitization. indications as at 17 june 2003: for the emergency treatment of anaphylax
adrenaline jr viatris adrenaline (epinephrine) 0.15 mg/0.3 ml injection syringe auto-injector
alphapharm pty ltd - adrenaline (epinephrine), quantity: 0.5 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; sodium chloride; hydrochloric acid - for the emergency treatment of anaphylactic reactions to insect stings through immediate self administration by individuals with a history of hypersensitivity to insect stings. adrenaline mylan and adrenaline jr mylan are designated as emergency supportive therapy only and are not a replacement or substitute for subsequent medical or hospital care, nor are they intended to supplant insect venom hyposensitization. indications as at 17 june 2003: for the emergency treatment of anaphylaxis (acute severe allergic reactions) due to insect stings, drugs or other allergens.
adrenaline viatris adrenaline (epinephrine) 0.3 mg/0.3 ml injection syringe auto-injector
alphapharm pty ltd - adrenaline (epinephrine), quantity: 1 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; water for injections; hydrochloric acid - for the emergency treatment of anaphylactic reactions to insect stings through immediate self administration by individuals with a history of hypersensitivity to insect stings. adrenaline mylan and adrenaline jr mylan are designated as emergency supportive therapy only and are not a replacement or substitute for subsequent medical or hospital care, nor are they intended to supplant insect venom hyposensitization. indications as at 17 june 2003: for the emergency treatment of anaphylaxis (acute severe allergic reactions) due to insect stings, drugs or other allergens.
ferinject iron (as ferric carboxymaltose) 1000 mg/20 ml injection vial
seqirus pty ltd - ferric carboxymaltose, quantity: 3.6 g (equivalent: iron, qty 1000 mg) - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - ferinject is indicated for the treatment of iron deficiency in adults and adolescents aged 14 years and older when:,? oral iron preparations are ineffective ? oral iron preparations cannot be used ? there is a clinical need to deliver iron rapidly,the diagnosis of iron deficiency must be based on laboratory tests.,ferinject is indicated for the treatment of iron deficiency anaemia in children aged 1 to 13 years when:,? oral iron preparations are ineffective ? oral iron preparations cannot be used,the diagnosis of iron deficiency anaemia must be based on laboratory tests.
perisyl perindopril erbumine 4 mg tablet blister pack
alphapharm pty ltd - perindopril erbumine, quantity: 4 mg - tablet - excipient ingredients: lactose; colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate; sodium bicarbonate; chlorophyllin-copper complex aluminium lake - perisyl is indicated for: ,1) the treatment of hypertension; ,2) the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril has not been demonstrated for new york heart association category iv patients); and ,3) patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.
perisyl perindopril erbumine 8 mg tablet blister pack
alphapharm pty ltd - perindopril erbumine, quantity: 8 mg - tablet - excipient ingredients: lactose; microcrystalline cellulose; magnesium stearate; sodium bicarbonate; colloidal anhydrous silica; chlorophyllin-copper complex aluminium lake - perisyl is indicated for: ,1) the treatment of hypertension; ,2) the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril has not been demonstrated for new york heart association category iv patients); and ,3) patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.
perisyl perindopril erbumine 2 mg tablet blister pack
alphapharm pty ltd - perindopril erbumine, quantity: 2 mg - tablet - excipient ingredients: chlorophyllin-copper complex aluminium lake; lactose; magnesium stearate; colloidal anhydrous silica; sodium bicarbonate; microcrystalline cellulose - perisyl is indicated for: ,1) the treatment of hypertension; ,2) the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril has not been demonstrated for new york heart association category iv patients); and ,3) patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.
meloxicam viatris meloxicam 7.5 mg tablet blister pack
helix pharmaceuticals pty ltd - meloxicam, quantity: 7.5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; povidone; magnesium stearate; sodium citrate dihydrate; colloidal anhydrous silica; crospovidone; microcrystalline cellulose - meloxicam is indicated for symptomatic treatment of osteoarthritis and rheumatoid arthritis.
meloxicam viatris meloxicam 15 mg tablet blister pack
helix pharmaceuticals pty ltd - meloxicam, quantity: 15 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; sodium citrate dihydrate; povidone; crospovidone - meloxicam is indicated for symptomatic treatment of osteoarthritis and rheumatoid arthritis.